Luminal Toxin-Binding Agents for Clostridium difficile Infection

Conclusion: LTBA monotherapy is inferior to vancomycin and metronidazole for CDI. Some data indicate possible benefit in reducing recurrent CDI, but outcomes with adjunctive and/or sequential LTBAs are unavailable. Further studies are needed to investigate the role of LTBAs for CDI.
Source: Journal of Pharmacy Practice - Category: Drugs & Pharmacology Authors: Tags: Research Articles Source Type: research